Details for New Drug Application (NDA): 204165
✉ Email this page to a colleague
The generic ingredient in CLOPIDOGREL BISULFATE is clopidogrel bisulfate. There are fifty-four drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the clopidogrel bisulfate profile page.
Summary for 204165
Tradename: | CLOPIDOGREL BISULFATE |
Applicant: | Sciegen Pharms Inc |
Ingredient: | clopidogrel bisulfate |
Patents: | 0 |
Pharmacology for NDA: 204165
Mechanism of Action | Cytochrome P450 2C8 Inhibitors P2Y12 Receptor Antagonists |
Physiological Effect | Decreased Platelet Aggregation |
Suppliers and Packaging for NDA: 204165
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 204165 | ANDA | Vensun Pharmaceuticals, Inc. | 42543-713 | 42543-713-01 | 100 TABLET in 1 BOTTLE (42543-713-01) |
CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 204165 | ANDA | Vensun Pharmaceuticals, Inc. | 42543-713 | 42543-713-05 | 500 TABLET in 1 BOTTLE (42543-713-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | Sep 15, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 300MG BASE | ||||
Approval Date: | Sep 15, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription